Skip to main navigation Skip to search Skip to main content

The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: Rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)

  • Charlotte Höybye
  • , Lars Sävendahl
  • , Henrik Thybo Christesen
  • , Peter Lee
  • , Birgitte Tønnes Pedersen
  • , Michael Schlumpf
  • , John Germak
  • , Judith Ross

Research output: Contribution to journal › Review article › peer-review

46   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: Rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science